Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2

Kathleen I. Pritchard; Howard A. Burris; Yoshinori Ito; Hope S. Rugo; Shaker Dakhil; Gabriel N. Hortobagyi; Mario Campone; Tibor Csöszi; José Baselga; Puttisak Puttawibul; Martine Piccart; Daniel Heng; Shinzaburo Noguchi; Vichien Srimuninnimit; Hugues Bourgeois; Antonio Gonzalez Martin; Karen Osborne; Ashok Panneerselvam; Tetiana Taran; Tarek Sahmoud; Michael Gnant

Safety and Efficacy of Everolimus With Exemestane vs. Exemestane Alone in Elderly Patients With HER2-Negative, Hormone Receptor–Positive Breast Cancer in BOLERO-2

Abstract

Abstract is not available.

journal-article

Similar works

Full text

Crossref

Last time updated on 11/12/2019

This paper was published in Crossref.

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.